May 22, 2018
BioLineRx Reports First Quarter 2018 Financial Results
May 17, 2018
BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients
May 17, 2018
BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy in Stem Cell Mobilization for Allogeneic Bone Marrow Transplantation
May 16, 2018
BioLineRx to Report First Quarter 2018 Results on May 22, 2018